Skip to main content
. Author manuscript; available in PMC: 2013 Feb 19.
Published in final edited form as: Neuroscience. 2011 Sep 17;197:72–79. doi: 10.1016/j.neuroscience.2011.09.027

Figure 3. Ketamine-xylazine (KX) treatment increases brain energy levels.

Figure 3

Increased brain energy levels after KX treatment. The concentrations of ADP increased significantly in all tested brain regions. PCr and Cr changed only in FC and CCX. Consistent with the ATP and ADP increases, there were significant decreases in AMP and AD concentrations in FC, BF and CCX. Statistical analysis was performed using ANOVA followed by Student-Newman-Keuls post-hoc analysis. *P < 0.05 versus control treatment.